Monogram Announces 2008 Second Quarter Financi... (in is a registered trademark of Genentec...)

Monogram Announces 2008 Second Quarter Financial Results

Date:7/29/2008

in is a registered trademark of Genentech, Inc. Selzentry is a trademark of Pfizer Inc.

MONOGRAM BIOSCIENCES, INC.

SELECTED STATEMENT OF OPERATIONS DATA

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Revenue:

Product revenue $15,440 $8,907 $29,447 $18,006

Contract revenue 687 485 1,506 803

License revenue 5 300 15 300

Total revenue 16,132 9,692 30,968 19,109

Operating costs and expenses:

Cost of product revenue 7,124 5,327 13,488 11,032

Research and development 6,244 5,176 12,268 10,507

Sales and marketing 4,133 4,159 8,485 8,102

General and administrative 4,163 3,629 8,729 7,857

Total operating costs and expenses 21,664 18,291 42,970 37,498

Operating loss (5,532) (8,599) (12,002) (18,389)

Convertible debt valuation adjustment

and interest income/(expense), net (58) 4,727 4,684 717

Contingent Value Rights

valuation adjustment 72 - 72 -

Net loss before cumulative effect of

change in accounting principle (5,518) (3,872) (7,246) (17,672)

Cumulative effect of change in

accounting principle - - - 2,242

Net loss after cumulative effect of

change in accounting principle $(5,518) $(3,872) $(7,2
'/>"/>

Post Your Comments:

Monogram Announces 2008 Second Quarter Financi...(in is a registered trademark of Genentec...),Health